NCT04447937Unknown不适用
Analysis of Medical Therapy and History as Risks of Immunodeficiency in Multiple Sclerosis Patients
Advanced Neurosciences Institute1 个研究点 分布在 1 个国家目标入组 1,500 人开始时间: 2020年6月29日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 发起方
- 入组人数
- 1,500
- 试验地点
- 1
- 主要终点
- Immunoglobulin Levels
研究概览
简要总结
The purpose of this study is to identify if there is a relationship between multiple sclerosis disease-modifying therapy exposure, immunodeficiencies, and infection risk in subjects living with MS.
详细描述
The purpose of this study is to identify if there is a relationship between multiple sclerosis disease-modifying therapy exposure, immunodeficiencies, and infection risk in subjects living with MS. By understanding this relationship future studies can be designed to create a model of immunosenescence in multiple sclerosis, which could help healthcare providers to predict and assess health risks. Preventative strategies can then be tested to look for ways to prevent these immune-related risks.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Retrospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- •No evidence of CNS autoimmune disease
- •Less than 18 years of age at the time of data abstraction
- •Undergoing plasma exchange at the time of any lab tests drawn
结局指标
主要结局
Immunoglobulin Levels
时间窗: 1 year
IgG, IgA, IgM
次要结局
- Infections(1 year)
- Immune-mediated conditions(1 year)
- Malignant and pre-malignant conditions(1 year)
研究者
研究点 (1)
Loading locations...
相似试验
Unknown
不适用
Analysis of MS Patients Who Have Had Greater Than 60 Infusions of NatalizumabMultiple SclerosisNCT04964700Multiple Sclerosis Center of Northeastern New York42
招募中
1 期
Safety and Efficacy of Intrathecal Rituximab in Patients With Multiple SclerosisMultiple SclerosisNCT05078177St. Petersburg State Pavlov Medical University40
已完成
4 期
Does Quality of Life Improve in Multiple Sclerosis Patients Treated With Interferon Beta-1a?Relapsing Remitting Multiple SclerosisNCT00534261Biogen284
已完成
不适用
Retrospective Analysis Assessing Clinical Risk Factors for Cardiovascular Events and Mortality and Development of a Risk Calculator in Chronic Kidney Disease Stage 5 on DialysisChronic Kidney Disease (CKD)NCT04042350Astellas Pharma Europe Ltd.2,773
已完成
不适用
Effects of the Cross-Training in Patients With Multiple SclerosisWeaknessFatigueMultiple SclerosisNCT02010398Università degli Studi di Sassari45